Healthcare provider profile · identity verified

Dushyant Viswanathan, M.D.

Internal Medicine · WOODLAND HILLS, CA · NPI 1285897421

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	313	100
Levothyroxine Sodium	Levothyroxine Sodium	240	67
Metformin Hcl	Metformin Hcl	224	66
Pantoprazole Sodium	Pantoprazole Sodium	183	51
Amlodipine Besylate	Amlodipine Besylate	165	52
Tamsulosin Hcl	Tamsulosin Hcl	162	49
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	158	32
Eliquis	Apixaban	140	37
Albuterol Sulfate Hfa	Albuterol Sulfate	128	47
Furosemide	Furosemide	116	58
Gabapentin	Gabapentin	115	52
Losartan Potassium	Losartan Potassium	109	33
Omeprazole	Omeprazole	100	29
Finasteride	Finasteride	92	29
Lisinopril	Lisinopril	91	36
Metoprolol Succinate	Metoprolol Succinate	91	30
Carvedilol	Carvedilol	79	22
Hydrochlorothiazide	Hydrochlorothiazide	77	20
Potassium Chloride	Potassium Chloride	75	29
Lorazepam	Lorazepam	72	22
Jardiance	Empagliflozin	71	24
Famotidine	Famotidine	59	23
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	59	suppressed
Ozempic	Semaglutide	58	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	56	suppressed
Clonidine Hcl	Clonidine Hcl	55	18
Tramadol Hcl	Tramadol Hcl	52	22
Glipizide	Glipizide	50	15
Hydralazine Hcl	Hydralazine Hcl	50	22
Rosuvastatin Calcium	Rosuvastatin Calcium	50	18
Trazodone Hcl	Trazodone Hcl	50	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	19
Alprazolam	Alprazolam	46	suppressed
Montelukast Sodium	Montelukast Sodium	45	15
Alcohol Prep Pads	Alcohol Antiseptic Pads	44	24
Alendronate Sodium	Alendronate Sodium	43	12
Januvia	Sitagliptin Phosphate	43	suppressed
Nifedipine Er	Nifedipine	43	16
Metoprolol Tartrate	Metoprolol Tartrate	42	15
Comfort Ez Pen Needle	Pen Needle, Diabetic	41	19
Spironolactone	Spironolactone	40	12
Simvastatin	Simvastatin	39	11
Donepezil Hcl	Donepezil Hcl	37	15
Clopidogrel	Clopidogrel Bisulfate	35	13
Fluconazole	Fluconazole	35	22
Memantine Hcl	Memantine Hcl	33	12
Mirtazapine	Mirtazapine	33	11
Quetiapine Fumarate	Quetiapine Fumarate	33	11
Valsartan	Valsartan	33	suppressed
Fluticasone Propionate	Fluticasone Propionate	32	suppressed
Levetiracetam	Levetiracetam	32	14
Oxycodone Hcl	Oxycodone Hcl	32	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	31	13
Hydrocortisone	Hydrocortisone	31	21
Atenolol	Atenolol	29	suppressed
Cyclosporine	Cyclosporine	29	15
Diflorasone Diacetate	Diflorasone Diacetate	29	21
Escitalopram Oxalate	Escitalopram Oxalate	29	suppressed
Humalog Kwikpen U-100	Insulin Lispro	28	suppressed
Latanoprost	Latanoprost	28	14
Metformin Hcl Er	Metformin Hcl	25	11
Pregabalin	Pregabalin	25	suppressed
Progesterone	Progesterone, Micronized	25	12
Glimepiride	Glimepiride	24	suppressed
Morphine Sulfate Er	Morphine Sulfate	24	suppressed
Ondansetron Odt	Ondansetron	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	22	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Linzess	Linaclotide	22	suppressed
Mounjaro	Tirzepatide	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Glipizide Er	Glipizide	21	suppressed
Ibuprofen	Ibuprofen	21	11
Xarelto	Rivaroxaban	21	suppressed
Allopurinol	Allopurinol	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Rybelsus	Semaglutide	20	suppressed
Clonazepam	Clonazepam	19	suppressed
Naproxen	Naproxen	19	suppressed
Olanzapine	Olanzapine	19	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	17	suppressed
Mupirocin	Mupirocin	17	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	16	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Citalopram Hbr	Citalopram Hydrobromide	16	suppressed
Lumigan	Bimatoprost	16	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	16	suppressed
Nystatin	Nystatin	16	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	16	suppressed
Atrovent Hfa	Ipratropium Bromide	15	suppressed
Celecoxib	Celecoxib	15	suppressed
Duloxetine Hcl	Duloxetine Hcl	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	13
Sertraline Hcl	Sertraline Hcl	14	suppressed
Digoxin	Digoxin	13	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Fentanyl	Fentanyl	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Restasis	Cyclosporine	13	suppressed
Santyl	Collagenase Clostridium Hist.	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Baclofen	Baclofen	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Dexamethasone	Dexamethasone	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Methenamine Hippurate	Methenamine Hippurate	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Ceftriaxone	Ceftriaxone Sodium	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Fiasp Penfill	Insulin Aspart (Niacinamide)	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Lactulose	Lactulose	11	suppressed
Omeprazole-Sodium Bicarbonate	Omeprazole/Sodium Bicarbonate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error